HansBiomed Valuation
| 042520 Stock | KRW 13,180 130.00 0.98% |
At this time, the firm appears to be overvalued. HansBiomed retains a regular Real Value of W10807.6 per share. The prevalent price of the firm is W13180.0. Our model calculates the value of HansBiomed from evaluating the firm fundamentals such as Current Valuation of 184.7 B, return on equity of 13.65, and Return On Asset of -0.0946 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage taking in undervalued assets and trading overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that HansBiomed's price fluctuation is very steady at this time. Calculation of the real value of HansBiomed is based on 3 months time horizon. Increasing HansBiomed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for HansBiomed is useful when determining the fair value of the HansBiomed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of HansBiomed. Since HansBiomed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HansBiomed Stock. However, HansBiomed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13180.0 | Real 10807.6 | Hype 13180.0 | Naive 13445.06 |
The real value of HansBiomed Stock, also known as its intrinsic value, is the underlying worth of HansBiomed Company, which is reflected in its stock price. It is based on HansBiomed's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of HansBiomed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HansBiomed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of HansBiomed helps investors to forecast how HansBiomed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HansBiomed more accurately as focusing exclusively on HansBiomed's fundamentals will not take into account other important factors: HansBiomed Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining HansBiomed's current stock value. Our valuation model uses many indicators to compare HansBiomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HansBiomed competition to find correlations between indicators driving HansBiomed's intrinsic value. More Info.HansBiomed is number one stock in price to earning category among related companies. It is number one stock in price to sales category among related companies fabricating about 0.04 of Price To Sales per Price To Earning. The ratio of Price To Earning to Price To Sales for HansBiomed is roughly 26.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value HansBiomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HansBiomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HansBiomed's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HansBiomed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HansBiomed and how it compares across the competition.
About HansBiomed Valuation
The stock valuation mechanism determines the current worth of HansBiomed on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of HansBiomed. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of HansBiomed based exclusively on its fundamental and basic technical indicators. By analyzing HansBiomed's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of HansBiomed's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of HansBiomed. We calculate exposure to HansBiomed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HansBiomed's related companies.HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct HansBiomed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HansBiomed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HansBiomed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HansBiomed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HansBiomed's revenue streams: Identify HansBiomed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HansBiomed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HansBiomed's growth potential: Evaluate HansBiomed's management, business model, and growth potential.
- Determine HansBiomed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HansBiomed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HansBiomed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the HansBiomed information on this page should be used as a complementary analysis to other HansBiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |